Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W6LW
|
|||
| Former ID |
DCL001159
|
|||
| Drug Name |
BIT225
|
|||
| Synonyms |
BIT-225; BIT225; 917909-71-8; SCHEMBL3109704; CHEMBL1242296; WVROWPPEIMRGAB-UHFFFAOYSA-N; ZINC43151503; 2-Naphthalenecarboxamide, N-(aminoiminomethyl)-5-(1-methyl-1H-pyrazol-4-yl)-; SB16851; 5-(1-methyl-1H-pyrazol-4-yl)-2-naphthoylguanidine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Phase 1 | [1] | |
| Company |
Biotron
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H15N5O
|
|||
| Canonical SMILES |
CN1C=C(C=N1)C2=CC=CC3=C2C=CC(=C3)C(=O)N=C(N)N
|
|||
| InChI |
1S/C16H15N5O/c1-21-9-12(8-19-21)13-4-2-3-10-7-11(5-6-14(10)13)15(22)20-16(17)18/h2-9H,1H3,(H4,17,18,20,22)
|
|||
| InChIKey |
WVROWPPEIMRGAB-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 917909-71-8
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human immunodeficiency virus Protease (HIV PR) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 2011 Pipeline of Biotron. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.